SEC Filings
Expansion signals pulled from 10-K and 10-Q filings via EDGAR, classified by AI.
…We believe that cash available from operations, including our cash resources and access to credit, will be sufficient for our working capital needs, including purchase commitments for raw materials and inventory, increases in accounts receivable, payments of tax liabilities, expansion and development requirements, purchases of capital assets, purchases of equipment, purchases of real property and purchases of shares of our common stock, through at least the next 12 months.…
…To a lesser extent, for both the three-months ended March 31, 2026 and 2025, cash used in investing activities also included the acquisitions of fixed assets consisting of vans and promotional vehicles, coolers and other equipment to support our marketing and promotional activities, production equipment, furniture and fixtures, office and computer equipment, equipment used for sales and administrative activities, certain leasehold improvements, as well as construction of and/or improvements to real property.…
…Capital expenditures in the period primarily related to ongoing projects in our Post Consumer Brands and Foodservice segments.…
…The Company's cereal manufacturing facility in Ashton-under-Lyne in the United Kingdom, which is reported in the Weetabix segment, was classified as held for sale at March 31, 2026.…
…In March 2025, the Company finalized its plan to close its Post Consumer Brands cereal manufacturing facilities in Sparks, Nevada and Cobourg, Ontario.…
…We made payments of $139 million for purchases of property, plant, and equipment during the fiscal three months ended March 29, 2026.…
…Net cash flows used in investing activities were primarily driven by purchases of property, plant, and equipment in both the fiscal three months ended March 29, 2026 and March 30, 2025.…
…The relocation to this new campus from multiple U.S.-based locations will continue throughout 2026 when the new research and development building is expected to be complete by the end of 2026.…
…On April 20, 2023, the Company entered into a long-term lease for a newly renovated global and North America corporate headquarters building and a newly constructed research and development building in Summit, New Jersey.…
…Our ability to penetrate or expand our operations in emerging markets, which depends on local economic and political conditions, and how well we are able to make necessary infrastructure enhancements to production facilities and distribution networks.…
…While BD's ethylene oxide sterilization facilities received this Presidential compliance exemption we continue to implement certain changes to our facilities in accordance with the revised NESHAP's requirements, and such measures will require additional implementation and ongoing operational costs, including investments in certain new technologies.…
…To this end, BD has proactively installed fugitive emissions controls at our facilities in East Columbus, NE and Sandy, UT.…
…The ultimate resolution of the El Paso Warning Letter and its impact on BD's operations is unknown at this time.…
…Until the violations are completely addressed and the FDA confirms the site's compliance, the FDA is likely to withhold the issuance of Export Certificates on drug or drug-led combination products manufactured at the El Paso site and withhold approval of new applications or supplements that list the site as a drug manufacturer.…
…On April 30, 2026, BD's El Paso manufacturing facility received a Warning Letter from the FDA following an inspection conducted in October 2025 related to drug-device combination products manufactured at the site, including ChloraPrep TM and PurPrep TM (the "El Paso Warning Letter").…
…These simplification and other cost-saving initiatives are focused on organizational realignment related to the separation of the Company's former Biosciences and Diagnostic Solutions business, as well as alignment with BD's current operational strategy, Excellence Unleashed, and are intended to reduce complexity, optimize the Company's supply chain efficiency, streamline its global manufacturing footprint, enhance product quality, refine customer experience, and improve cost efficiency across all of the Company's segments.…
…Our investments in capital expenditures are focused on projects that enhance our cost structure and manufacturing capabilities, as well as support the objectives of our growth strategy.…
…We expect 2026 capital expenditures to be approximately $900 million compared to the 2025 capital expenditures of $801 million. Our 2026 capital expenditures are expected to be primarily driven by maintenance projects, capital investments focused on generating growth, and investments in technology.…
…In June 2023, we entered into a non-cancellable synthetic lease for a distribution facility, for which we are the construction agent, for which we now anticipate the estimated construction cost to be approximately $625 million.…
…The net assets to be transferred in the Italy Infant Transaction include, among other things, our intellectual property rights to the Plasmon and Nipiol brands and one manufacturing facility in Italy (collectively, the "Italy Infant Disposal Group").…
…In April 2026, the Company announced plans to construct a new two-line, high-speed beverage can plant in Northern India. This plant is expected to commence operations in the second half of 2027.…
…To meet volume requirements, the Company plans to add additional line capacity in Korinthos, Greece and Agoncillo, Spain in late 2026.…
…In May 2025, the Company announced it will add a new high-speed production line to its beverage can plant in Ponta Grossa, Brazil. The line is expected to commence commercial production in late 2026.…
…While the Company continues to pursue mitigation actions as necessary with respect to its tariff exposure, including pricing actions, productivity initiatives, sourcing diversification and manufacturing footprint optimization, changes in trade policy, related legal challenges and geopolitical responses could continue to adversely affect the Company's costs, supply chain and financial results.…
…Restructuring-related costs reported in selling, general and administrative expense ("SG&A") for the three months ended March 31, 2026 was $1 million and primarily related to facility closures associated with previously announced but substantially completed restructuring activities.…
…Despite the U.S. Supreme Court ruling that tariffs imposed under the International Emergency Economic Powers Act ("IEEPA") tariffs were unconstitutional, the Company continues to deploy a mitigation strategy designed to offset the impact of tariff exposure through a number of actions, including pricing, productivity and in some cases relocation of manufacturing.…
…The Company continues to focus its capital spending on projects that are expected to yield high after-tax returns.…
…Capital expenditures were $138 in the first three months of 2026 compared to $124 in the first three months of 2025.…
…We are engaged in manufacturing and sourcing of products and materials on a global scale and have major manufacturing facilities, warehousing facilities and distribution centers in every region around the world.…
…The program includes initiatives to better align our organizational structure to support our strategic initiatives, optimize our global supply chain to drive agility and efficiencies and simplify and streamline our organizational structure to reduce overhead costs.…
…Property, plant and equipment: Cost 10,887 10,856 Less: Accumulated depreciation ( 6,265 ) ( 6,196 ) Property, plant and equipment, net 4,622 4,660…
…We anticipate that our cash from operations, together with our current borrowing capacity, will be sufficient to fund our share repurchase programs to the extent implemented by management, pay debt and interest as it comes due, pay dividends at the latest approved rate, and meet our capital expenditure program costs, which are expected to be approximately $130.0 in 2026 including manufacturing capacity investments for THERABREATH® and Sterimar and an enterprise resource planning (ERP) project.…
…We continue to evaluate these evolving developments and have taken actions to mitigate their impact on our business, including exiting certain business lines, shifting production and relocating manufacturing operations, finding alternative sources of supply, selectively increasing prices, adjusting inventories, seeking exemptions with respect to tariffs, and most notably ceasing the import of substantially all Waterpik flossers and certain other products from China into the U.S.…
…This agreement includes the VitaFusion and L'il Critters brands, relevant trademarks and licenses, and the Company's former manufacturing and distribution facilities in Vancouver and Ridgefield, Washington.…
…The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment.…
…Property, plant and equipment expenditures included in Accounts Payable $ 14.4 $ 13.1…
…Additions to property, plant and equipment ( 31.9 ) ( 16.5 )…
…Construction in progress 147.6 131.9…
…Capital expenditures were incurred primarily for growth projects, to improve operational efficiencies, and to reduce costs for the three months ended March 29, 2026.…
…Acquisitions of property, plant and equipment $ (234.8) $ (98.3)…
…During the three months ended March 29, 2026, the Company incurred $236.2 million on capital projects and transferred $115.2 million of completed projects from construction-in-progress to depreciable assets.…
…Construction-in-progress 745,247 667,315…
…We operate feed mills, hatcheries, processing plants and distribution centers in 14 U.S. states, the U.K., Mexico, France, Puerto Rico, the Netherlands and the Republic of Ireland.…
…We are making investments in global facilities to manufacture existing and future products. These investments, and other capital investments that support our operations, have increased our capital expenditures and will result in meaningfully higher capital expenditures in the near term.…
…To support anticipated demand for our current and prospective products, we have undertaken significant manufacturing expansion initiatives. Additional capacity is expected to become operational over the next several years.…
…Purchases of property and equipment ( 2,326 ) ( 1,510 )…
…Property and equipment, net 26,540 24,675…
…During the three months ended April 3, 2026, the Company recorded other operating charges of $21 million. These charges included $10 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $4 million related to North America modernization initiatives, $4 million for the amortization of noncompete agreements related to the BodyArmor acquisition in 2021 and $3 million related to tax litigation expense.…
…Our current capital allocation priorities are as follows: investing wisely to support our business operations, continuing to grow our dividend payment, enhancing our beverage portfolio and capabilities through consumer-centric acquisitions, and using excess cash to repurchase shares over time. We currently expect 2026 capital expenditures to be approximately $2.2 billion.…
…Purchases of property, plant and equipment during the three months ended April 3, 2026 and March 28, 2025 were $266 million and $309 million, respectively.…
…Capital expenditures during the nine months ended March 31, 2026 and 2025 were $385 million and $315 million, respectively.…
…During the three and nine months ended March 31, 2026 and 2025, restructuring and employee severance costs were primarily related to the implementation of certain enterprise-wide cost-savings measures and certain initiatives to rationalize our manufacturing operations.…
…These efforts have included restructuring the organization into verticalized segments, optimizing our manufacturing footprint, R&D operations, and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions.…
…In recent years, these efforts have included restructuring the organization into verticalized segments, optimizing the manufacturing footprint, R&D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions, some of which are still ongoing.…
…The acquired net tangible assets consist primarily of property, plant, and equipment; trade accounts receivable; trade accounts payable; other current liabilities; and other non-current liabilities.…
…Additions to Property and Equipment Three Months Ended March 31, Three Months Ended March 31, (in millions) 2026 2025 Established Pharmaceuticals $ 20 $ 33 Nutritional Products 40 79 Diagnostic Products 128 135 Medical Devices 147 156 Total Reportable Segments 335 403 Other 56 60 Total $ 391 $ 463…
…Acquisitions of property and equipment ( 399 ) ( 484 )…
…These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses.…
…Construction in progress 1,270 1,201…
…During the three months ended March 31, 2026, our capital spending was $424 compared to $204 in the prior year. We anticipate that full year capital spending will be approximately $1.3 billion, including incremental spending from the 2024 Transformation Initiative.…
…We are a global company focused on delivering products and solutions that provide better care for a better world, with manufacturing facilities in 30 countries, including our equity affiliates, and products sold in more than 175 countries and territories.…
…We have integrated the production of our heated tobacco units into several of our existing manufacturing facilities, are progressing with our plans to build manufacturing capacity for our other SFPs, and continue to optimize our manufacturing infrastructure and expand our commercialization activities for new products and markets.…
…The program also includes the closure of the cigar manufacturing facility in Dothan, Alabama and the consolidation of its cigar production operations into PMI's manufacturing footprint in the Dominican Republic.…
…The program also includes the closure of the cigar manufacturing facility in Dothan, Alabama and the consolidation of its cigar production operations into PMI's manufacturing footprint in the Dominican Republic.…
…We have integrated the production of our heated tobacco units into several of our existing manufacturing facilities, are progressing with our plans to build manufacturing capacity for our other SFPs, and continue to optimize our manufacturing infrastructure and expand our commercialization activities for new products and markets.…
…As a result, we expect to incur pre-tax charges of approximately $6.15 billion, including cash expenditures of approximately $5.1 billion. These pre-tax charges are expected to consist of approximately 50% of severance and other employee-related costs, 15% for asset impairments (all non-cash) resulting from plant closures and related actions, and 35% for other costs associated with the implementation of our initiatives.…
…These new or increased legal or regulatory requirements, along with initiatives to meet our sustainability goals, could result in significant increased costs and additional investments in facilities and equipment.…
…These pre-tax charges are expected to consist of approximately 50% of severance and other employee-related costs, 15% for asset impairments (all non-cash) resulting from plant closures and related actions, and 35% for other costs associated with the implementation of our initiatives.…
…The 2019 Productivity Plan leverages new technology and business models to further simplify, harmonize and automate processes; re-engineers our go-to-market and information systems, including deploying the right automation for each market; and simplifies our organization and optimizes our manufacturing and supply chain footprint.…
…In addition, we spent $356 million on purchases of land, buildings, and equipment in the nine-month period ended February 22, 2026, compared to $405 million in the same period last year.…
…Under our supply chain organization, our manufacturing, warehouse, and distribution activities are substantially integrated across our operations in order to maximize efficiency and productivity.…
…In fiscal 2026, we approved a multi-year organizational initiative to increase the competitiveness of our supply chain, and as a result, we recorded $17 million of charges in the third quarter of fiscal 2026.…
…Capital expenditures supporting growth opportunities in fiscal 2026 are expected to focus on projects related to infrastructure, new data and technology, and equipment upgrades.…
…Significant projects during fiscal 2025 included the transition from harvest to value-added capacity for Hormel Fire Braised products and Applegate products at the Company's facility in Barron, Wisconsin, and equipment upgrades for chili production in Beloit, Wisconsin.…
…Significant projects during fiscal 2025 included the transition from harvest to value-added capacity for Hormel Fire Braised products and Applegate products at the Company's facility in Barron, Wisconsin, and equipment upgrades for chili production in Beloit, Wisconsin.…
…The largest projects during fiscal 2026 were related to capacity expansion at the ambient meat snack facility in Jiaxing, China, and investments in data and technology.…